Literature DB >> 15356148

Characterization of a dipeptide motif regulating IFN-gamma receptor 2 plasma membrane accumulation and IFN-gamma responsiveness.

Sergio D Rosenzweig1, Owen M Schwartz, Margaret R Brown, Thomas L Leto, Steven M Holland.   

Abstract

The IFN-gammaR complex is composed of two IFN-gammaR1 and two IFN-gammaR2 polypeptide chains. Although IFN-gammaR1 is constitutively expressed on all nucleated cells, IFN-gammaR2 membrane display is selective and tightly regulated. We created a series of fluorescent-tagged IFN-gammaR2 expression constructs to follow the molecule's cell surface expression and intracellular distribution. Truncation of the receptor immediately upstream of Leu-Ile 255-256 (254X) created a receptor devoid of signaling that overaccumulated on the cell surface. In addition, this truncated receptor inhibited wild-type IFN-gammaR2 activity and therefore exerted a dominant negative effect. In-frame deletion (255Delta2) or alanine substitution (LI255-256AA) of these amino acids created mutants that overaccumulated on the plasma membrane, but had enhanced function. Single amino acid substitutions (L255A or I256A) had a more modest effect. In-frame deletions upstream (253Delta2), but not downstream (257Delta2), of Leu-Ile 255-256 also led to overaccumulation. A truncation within the IFN-gammaR2 Jak2 binding site (270X) led to a mutant devoid of function that did not overaccumulate and did not affect wild-type IFN-gammaR2 signaling. We have created a series of novel mutants of IFN-gammaR2 that have facilitated the identification of intracellular domains that control IFN-gammaR2 accumulation and IFN-gamma responsiveness. In contrast to IFN-gammaR1, not only dominant negative, but also dominant gain-of-function, mutations were created through manipulation of IFN-gammaR2 Leu-Ile 255-256. These IFN-gammaR2 mutants will allow fine dissection of the role of IFN-gamma signaling in immunity. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356148     DOI: 10.4049/jimmunol.173.6.3991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  A novel internalization motif regulates human IFN-γ R1 endocytosis.

Authors:  Judith Yancoski; Mohammed A Sadat; Nadia Aksentijevich; Andrea Bernasconi; Steven M Holland; Sergio D Rosenzweig
Journal:  J Leukoc Biol       Date:  2012-05-17       Impact factor: 4.962

2.  Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function.

Authors:  Eliana Ribechini; James A Hutchinson; Sabine Hergovits; Marion Heuer; Jörg Lucas; Ulrike Schleicher; Ana-Laura Jordán Garrote; Sarah J Potter; Paloma Riquelme; Heike Brackmann; Nora Müller; Hartmann Raifer; Ingolf Berberich; Magdalena Huber; Andreas Beilhack; Michael Lohoff; Christian Bogdan; Matthias Eyrich; Heike M Hermanns; Edward K Geissler; Manfred B Lutz
Journal:  Blood Adv       Date:  2017-06-07

Review 3.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 4.  Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.

Authors:  Ana Esteve-Solé; Ithaisa Sologuren; María Teresa Martínez-Saavedra; Àngela Deyà-Martínez; Carmen Oleaga-Quintas; Rubén Martinez-Barricarte; Andrea Martin-Nalda; Manel Juan; Jean-Laurent Casanova; Carlos Rodriguez-Gallego; Laia Alsina; Jacinta Bustamante
Journal:  Crit Rev Clin Lab Sci       Date:  2018-03-04       Impact factor: 6.250

5.  Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids.

Authors:  Kim M A De Kleijn; Kirsten R Straasheijm; Wieteke A Zuure; Gerard J M Martens
Journal:  Biomedicines       Date:  2022-04-29

Review 6.  Interferon gamma receptor: the beginning of the journey.

Authors:  Cédric M Blouin; Christophe Lamaze
Journal:  Front Immunol       Date:  2013-09-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.